Abstract Details
9/23/2018 | 1:15 PM - 2:15 PM | Diamond Ballroom I
Pre-session
CMV 101: What is Congenital CMV? Why is it Important? How Can it be Prevented?
This session is designed to be an overview of Congenital CMV. The presenter will cover basic information about transmission, prevention, prevalence, treatment, and intervention.
- Identify two updates on reducing impact of congenital CMV
- Describe Maternal CMV infection during pregnancy
- List two efforts being made to increase awareness of cCMV
Presentation:
17739_9761GailDemmler-Harrison.pdf
Handouts:
No handouts have been uploaded.
Gail Demmler-Harrison (Primary Presenter), gdemmler@bcm.edu;
|
ASHA DISCLOSURE: Financial - Receives Honoraria excluding diversified mutual funds,Speaker,Other financial benefit for Other activities from Merck & Co . Receives Grants for Other activities from Microgen Labs. Nonfinancial - No relevant nonfinancial relationship exists. |
|
AAA DISCLOSURE: Financial - Receives support from Merck & Company Microgen Laboratories. |